Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
GSK 3052230, HGS1036 (formerly FP-1039)
print preview
bookmark
share with colleague
General Information
Company
Five Prime Therapeutics Inc.
Description
Soluble fibroblast growth factor (FGF) receptor 1 (FGFR1) antagonist
Molecular Target
Fibroblast growth factor (FGF)
Mechanism of Action
Fibroblast growth factor (FGF) receptor antagonist
Latest Stage of Development
Phase I
Indication
Solid tumors
Partner
GlaxoSmithKline plc
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy